MedicineOncologySurgeryChemotherapyGynecologic OncologySurgical OncologyGastrointestinal Cancer SurgeryGynecologic Oncology SurgeryOvarian CancerOvarian NeoplasiaMalignant Ovarian TumorsMucinous NeoplasmsMucinous Ovarian TumorsOvarian Cytoreductive SurgeryOvarian Tumor SurgerySerous Ovarian TumorsStaging Laparoscopy
Four patients with pseudomyxoma peritonei associated with mucinous tumors of the ovary were treated with cytoreductive surgery followed by intraperitoneal (IP) 5-fluorouracil (5-FU). CA-125 was elevated in three, and ca cinoembryonic antigen (CEA) in one patient; both fell to within normal levels following treatment. Two patients underwent reassessment laparotomy and one a reassessment laparoscopy with no evidence of disease following chemotherapy. The fourth patient refused surgical reassessment but remains clinically free of disease. Intraperitoneal 5-FU appears to be effective in pseudomyxoma peritonei. Précis: Four patients with pseudomyxoma peritonei associated with ovarian tumors were successfully treated with surgery and intraperitoneal 5-FU.